Targeted Markets Ampersand Health operates in behavioral health with a focus on oncology, immunology, and inflammation, offering predictive health analytics and whole-person interventions. This creates sales opportunities with hospitals, health systems, and research institutions seeking real-world evidence and patient journey insights in long-term inflammatory and complex conditions.
Strategic Partnerships Recent partnerships with PharmStars and collaborations with academic and hospital networks indicate a readiness to co-develop and validate real-world evidence propositions. Leverage these relationships to propose joint studies, data analytics services, and platform integrations for pharma and biopharma customers.
Patient App Ecosystem Continuous product launches of disease-specific apps (My Derm, My Arthritis, My IBD Care) suggest a mature mobile health strategy. This presents upsell opportunities around digital therapeutics, remote monitoring, patient engagement modules, and data streams for clinical trials and post-market surveillance.
Global Reach with UK-US Focus With customers and collaborators across the UK and US, plus spinout lineage from London teaching hospitals, Ampersand Health is positioned to scale in North America and Europe. Target hospitals, health systems, and research consortia expanding into oncology and inflammatory diseases seeking cross-border real-world data capabilities.
Revenue Growth Signals Revenue size of 1–10 million and a lean employee base indicate agility and room for scalable analytics, software-as-a-service, and professional services. Propose tiered pricing for analytics licenses, managed services, and embedded diagnostic tools tailored to mid-market healthcare providers and research institutions.